CGC

Canopy Growth
CGC

$4.48

5.49%

Market Cap: $380M

About: Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include skincare products under Martha Stewart CBD and Storz & Bickel vaporizers. Canopy growth merged its US assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.

Employees: 1,029

Healthcare Medicinal Chemicals & Botanical Products

0

Funds holding %

of 6,686 funds

–

Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

177% more call options, than puts

Call options by funds: $123M | Put options by funds: $44.2M

42% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 36

3% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 36

0% more funds holding

Funds holding: 222 [Q1] → 223 (+1) [Q2]

1.67% less ownership

Funds ownership: 10.44% [Q1] → 8.77% (-1.67%) [Q2]

47% less capital invested

Capital invested by funds: $81.8M [Q1] → $43M (-$38.8M) [Q2]

See Fund Rankings

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target

$2

55%

downside

Avg. target

$2

55%

downside

High target

$2

55%

downside

1 analyst rating

0 positive

0%

0 neutral

0%

1 negative

100%

Piper Sandler

Michael Lavery

67% 1-year accuracy

20 / 30 met price target

55%downside

$2

Underweight

Maintained

9 Jul 2024

See Analyst Rankings

Financial journalist opinion

Based on 30 articles about CGC published over the past 30 days

Zacks Investment Research

Investors Heavily Search Canopy Growth Corporation (CGC): Here is What You Need to Know

Zacks.com users have recently been watching Canopy Growth (CGC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Investors Heavily Search Canopy Growth Corporation (CGC): Here is What You Need to Know

Trump's Marijuana Support Could Ignite Stock Surge – Are You Positioned To Benefit?

The cannabis market is abuzz following former President Donald Trump's recent comments supporting cannabis legalization in Florida.

Trump's Marijuana Support Could Ignite Stock Surge – Are You Positioned To Benefit?

MarijuanaStocks

Best Canadian Cannabis Stocks to Watch in September

Investors looking to capitalize on the growing cannabis market should watch top Canadian marijuana stocks this week. With the US cannabis industry projected to reach $41 billion by 2025, many Canadian companies are expanding their presence across the border. This expansion is driven by increasing legalization efforts and growing consumer demand. For example, recent news highlights the potential for federal legalization in the US, which could open up significant opportunities for Canadian companies. Investors should utilize technical analysis and proper risk management strategies to navigate this dynamic market. Analyzing price trends, volume, and support levels can provide valuable insights into potential stock movements.

Best Canadian Cannabis Stocks to Watch in September

Cannabis stocks rally as analyst hails pot as an ‘increasingly bipartisan' issue

Alliance Global Partners Aaron Grey sees Donald Trump's weekend statement on cannabis as a step forward.

Cannabis stocks rally as analyst hails pot as an ‘increasingly bipartisan' issue

STORZ & BICKEL Debuts Inaugural "Smokeless September Challenge" to Educate Consumers on the Advantages of Vaporization

Switch to Vaporizing and Try the VENTY TUTTLINGEN, Germany , Aug. 29, 2024 /PRNewswire/ - STORZ & BICKEL GmbH (" STORZ & BICKEL "), a world-leading manufacturer of high-end and medically certified vaporizers and a subsidiary of Canopy Growth Corporation ("Canopy Growth") (TSX: WEED) (NASDAQ: CGC), today announced the launch of a new inaugural campaign, the Smokeless September Challenge. This initiative invites consumers to take a break from combustion throughout September and experience the advantages of vaporizing with STORZ & BICKEL's latest device, the VENTY.

STORZ & BICKEL Debuts Inaugural "Smokeless September Challenge" to Educate Consumers on the Advantages of Vaporization

Here's why Tilray Brands, Canopy Growth, Curaleaf stocks have crashed

Cannabis stocks have crashed hard this year as concerns about the industry continued. The AdvisorShares Pure US Cannabis ETF (MSOS) stock has plunged by almost 14% this year and is down by over 46% from its highest point this year.

Here's why Tilray Brands, Canopy Growth, Curaleaf stocks have crashed

Must-buy stocks if Kamala Harris wins the U.S. election

The financial markets are closely monitoring the upcoming U.S. election, as the outcome will likely have significant implications for the broader economy. Both candidates, Donald Trump and Kamala Harris, have outlined their policies, which are expected to influence investment strategies.

Must-buy stocks if Kamala Harris wins the U.S. election

The Motley Fool

Canopy Growth's CEO Is Leaving: Is That a Sign of Trouble for the Cannabis Stock?

Canopy Growth CEO David Klein will retire at the end of the company's current fiscal year. While he has helped bring down expenses, profitability remains a big problem for the business.

Canopy Growth's CEO Is Leaving: Is That a Sign of Trouble for the Cannabis Stock?

Cannabis Stocks Slide as DEA Sets Post-Election Marijuana Hearing in December

Cannabis stocks slumped Tuesday after the Drug Enforcement Administration (DEA) announced a hearing that could reclassify marijuana as a less harmful, Schedule III drug won't come until Dec. 2—after the 2024 presidential election.

Cannabis Stocks Slide as DEA Sets Post-Election Marijuana Hearing in December

Schaeffers Research

3 Weed Stocks Sinking on Reclassification Hearing Update

The U.S. Drug Enforcement Administration (DEA) today announced a proposal hearing on the reclassification of marijuana as a less restricted Schedule III drug will happen on Dec. 2, after the presidential election.

3 Weed Stocks Sinking on Reclassification Hearing Update

See News Rankings